Comparing Intensive Weight Loss Program and Bariatric Surgery for Adults with Severe Obesity in the LightBAR Trial
Led by Carsten Dirksen · Updated on 2026-08-21
500
Participants Needed
14
Research Sites
1030 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the benefits and risks of an intensive weight loss intervention compared to bariatric surgery in adults with severe and complex obesity. The goal is to inform future care options for people for whom bariatric surgery is currently the only effective treatment. This randomized trial is led by Carsten Dirksen and aims to compare these approaches over a two-year period.
The intensive weight loss intervention includes three phases over two years an induction phase with total dietary replacements and behavioral support possibly combined with weight loss medication, a weight loss continuation phase involving gradual reintroduction of healthy foods, physical activity, and medication as needed, and a maintenance phase focusing on sustained healthy diet and activity with medication if required. The surgery group will receive either Roux-en-Y gastric bypass or sleeve gastrectomy.
Participants will be closely followed for two years after randomization with assessments including metabolic syndrome measures, body weight, walking speed, and mental health status. The study uses double-blind randomization and includes regular behavioral support and monitoring. The results will help understand which treatment offers better outcomes for adults aged 18 to 60 with severe obesity and related health conditions.
CONDITIONS
Brief Title
Intensive Weight Loss Intervention Versus Bariatric Surgery for Adults With Severe and Complex Obesity: the LightBAR Randomised Trial
Research Team
K
Kirstine N Bojsen-Møller, MD, PhD
S
Susan Jebb, Professor
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Aged 18 to 60 years (inclusive) at time of screening
Eligible for and willing to undergo bariatric surgery based on national health criteria
Fit for anesthesia and surgery
Provide informed consent
Achieved at least 5% weight loss within 12 weeks prior to randomization
You will not qualify if you...
Prior bariatric or hiatal surgery, except certain devices removed more than 1 year before screening
Use of weight loss medication within the last 3 months
Conditions that prevent or complicate total diet replacement or treatment with GLP-1 receptor analogues
Conditions that contraindicate bariatric surgery, such as certain gastrointestinal disorders or liver cirrhosis
Mental disorders or unstable psychiatric disease
Recent history of alcohol or medication abuse
Cancer treatment within the last 5 years
Pregnant, planning pregnancy in next 2 years, or breastfeeding
Participation in other obesity treatment research that conflicts with this trial
Household member already enrolled in the trial
Diagnosis or treatment of severe eating disorder within the last 6 months
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Treatment
Duration - 104 weeks
Participants receive either the intensive weight loss program with dietary replacements, behavioral support, and medication over three phases lasting two years, or undergo bariatric surgery such as Roux-en-Y gastric bypass or sleeve gastrectomy.
Regular visits throughout treatment phases
Follow-up
Duration - Up to 104 weeks
Participants are monitored for outcomes including metabolic syndrome status, weight, walking speed, and mental health scores up to 104 weeks after randomization.
Periodic assessments during and after treatment
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Virtual Nutrition Education to Prevent Weight Gain During Maintenance Chemotherapy in Children and Adolescents with Acute Lymphoblastic Leukemia
Study of Gene Expression in Tissues Related to Blood Sugar and Weight in Adults Undergoing Abdominal Surgery
Phase 1 Study of Single-Dose Semaglutide Nasal Spray to Assess Safety, Tolerability, and Pharmacokinetics in Adults with Overweight or Obesity Aged 18 to 65
Evaluating Multimodal Ultrasound to Monitor Muscle Mass in Metabolic Syndrome, Type 2 Diabetes, and Obesity
Reducing Obesity and Related Health Risks in Native American Employees at Twin Arrows Casino Using a Culturally Relevant Plant-Rich Diet
Study of Safety, Tolerability, and Effects of NNC0721-8060 Compared to Semaglutide and Placebo in Adults with Overweight or Obesity
Phase 12a Study Evaluating Safety and Effects of ARO-ALK7 in Adults With Obesity, With or Without Type 2 Diabetes
Master Protocol Evaluating Multiple Investigational Treatments for Chronic Weight Management in Adults with Obesity or Overweight
Evaluating a Digital Tool to Help Clinicians Prescribe Personalized Exercise for Adults with Cardiovascular Disease Risk Factors in a Randomized Crossover Trial
Testing a Responsive Parenting Program to Prevent Obesity in High-Risk Infants Through Pediatric Primary Care
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Time, money, and weight loss: a qualitative study exploring patients' perspectives on randomization for bariatric surgery vs. an intensive non-surgical weight loss program.
Sofie Amalie Tomova-Olsen, Marius Brostrøm Kousgaard, Katrine Tranberg Jensen...